ARCHIVES

FDA Approves Generic Oncology Injectable Currently In Shortage

This article is from The Cancer Letter archive.

Vol. 39 No. 36 | September 27, 2013

Download PDF Visit The Full Archive

Related Articles

Medenica Granted Extension Of Privileges At Hilton Head Hospital

November 26, 1993

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

In Brief: Wittes to Join Bristol-Myers As VP; Friedman Named Acting CTEP Director; Carl Pinsky Leaves

September 23, 1988

Budget Projections for 1978 Offer Clues On Research NCI Hopes To Fund

June 18, 1976

Intramural Clinical Research Could Lose “Critical Mass” – Chabner

November 11, 1994

New NCI Director Varmus “Glad To Be Back,” Says Goal Is To Control Cancer Through Science

July 16, 2010